Browsing Harvard Law School by Keyword "drug prices"
Now showing items 1-2 of 2
-
Equitable Division of International Joint Costs in Pharmaceutical Research and Development
(2004)Significant increases in pharmaceutical spending over the past two decades have lead to public outrage over the cost of prescription drugs. Pharmaceutical research and development is an expensive process – ... -
Medicaid Pharmacy Benefits Waiver Programs: A Deference Argument for Process in Informal Agency Actions
(2003)The proper level of judicial review for Section 1115 Medicaid demonstration program waiver (“waiverâ€) decisions made by the Secretary of the Department of Health and Human Services ...